Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @LocusBio
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LocusBio
-
Locus is proud to announce the start of its first clinical trial. See the full announcement at http://bit.ly/LocusPh1b
#CRISPR#Biotechnology#clinicaltrialspic.twitter.com/k7fNkeanO1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’ve been named to
@CNBC’s list of the 100 most promising startup companies in the world! Learn why CNBC thinks we’re on the way to becoming a household name: http://www.cnbc.com/upstart#Upstart100Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus co-founders Charles Gersbach
@DukeU and Rodolphe Barrangou@NCState@CRISPRlab@CRISPRchef were recognized for their groundbreaking work applying Type I CRISPR systems to eukaryotic cells.https://www.biocentury.com/bc-innovations/tools-techniques/2019-09-25/different-type-crispr-system-works-human-cells-creates- …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus is honored to be named to the 2019
#Fierce15 by@FierceBiotech. We appreciate Fierce's recognition of our hard work to address unmet medical needs in#AntibioticResistance and#microbiome diseases using#CRISPR.https://www.fiercebiotech.com/special-report/locus-biosciences …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus is honored to be named to the 2019
#Fierce15 by@FierceBiotech. We appreciate Fierce's recognition of our hard work to address unmet medical needs in#AntibioticResistance and#microbiome diseases using#CRISPR.https://twitter.com/FierceBiotech/status/1176068688245448705 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are honored to be recognized as Company of the Year by
@TriangleBIZJrnl#TBJLifeSciHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks
@NPR and@robsteinnews for excellent story on Locus#CRISPR enhanced#bacteriophage therapies for treating bacterial infections. We are excited to try to help heroes like Mr. Evans.#crPhage#AMR#superbugshttps://twitter.com/NPR/status/1131163043646230528 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus Biosciences proslijedio/la je Tweet
Great talk from Dave Ousterout of
@LocusBio on their#Crispr-Cas3-phage platform. They’re enrolling for an E. coli#phage clinical trial against UTIs & are excited to move toward#microbiome editing in the future.@MicrobiomeDaily#phagesummit2019Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@LocusBio is hiring! Open positions in business development, preclinical research, clinical development, and cGMP manufacturing of#CRISPR#Cas3 enhanced#bacteriophage products. Join the fight against#AMR and the hunt for#microbiome therapies at http://www.locus-bio.com/careers .Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus Biosciences Introducing crPhage: http://youtu.be/JgXood-oZ1A?a via
@YouTubeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks
@WIRED for the fantastic article - we're proud to be part of the#AMR fight using#CRISPR and thrilled to have@JNJInnovation back us. Antibiotics Are Failing Us. Crispr Is Our Glimmer of Hopehttps://www.wired.com/story/antibiotics-are-failing-us-crispr-is-our-glimmer-of-hope …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you know there are many types of
#CRISPR other than Cas9? See how#LocusLab uses#Cas3 to eliminate#AntibioticResistance with#crPhagehttps://www.youtube.com/watch?v=wWxXYujAirc …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus Biosciences is proud to announce a $818M collaboration with
@JNJInnovation to develop#crPhage precision therapeutics for critical needs respiratory infections. Read the press release here: https://www.locus-bio.com/press-releases/#CRISPR#Phage#AntibioticResistance#PrecisionMedicineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What is
#crPhage? Check out how@LocusBio is changing the fight against#AntibioticResistance by utilizing the power of#CRISPR and the specificity of#Phagehttps://www.youtube.com/watch?v=6-zV2mxquu4 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
See how
@LocusBio is revolutionizing#PrecisionMedicine with#crPhage and#CRISPR to eradicate#AntibioticResistance#antibiotics#PhageTherapy#Cas3#phagehttps://www.youtube.com/watch?v=q88b6bgCZ6c&t=2s …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Introducing crPhage™, a breakthrough innovation leveraging
#CRISPR#Cas3 to safely and precisely eliminate harmful bacteria in the#microbiome. Learn more: http://www.locus-bio.com pic.twitter.com/jkWjBgsWS8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to be selected Best Initial Venture Funding
@southeastbio and to be recognized alongside fellow#NorthCarolina companies@Liquidia_Inc,@PrecisionBioSci,@AdvChemoTech, Humacyte, Tellus Therapeutics, NeuroTronik,@SpyryxBio, and EternaTear.https://www.wraltechwire.com/2018/11/28/nc-companies-shine-at-sebio-forum/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big thank you to
@southeastbio for recognizing@LocusBio as a finalist for an SEBIO Award in the Initial Venture Funding category. Winners to be announced Nov-14 in Atlanta.https://twitter.com/ncbiotech/status/1055189941007933443 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus Biosciences proslijedio/la je Tweet
It is a pleasure to welcome panelists from
@BARDA,@US_FDA,@LocusBio,@HHSGov,@CidaraThera, and the @ContraFectCorporation for their Keynote Panel on the first day of#AMRCongressUSApic.twitter.com/3PFvjPzloy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Locus Biosciences proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.